These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 34522493)

  • 1. The Role of Vitamins in Non-Alcoholic Fatty Liver Disease: A Systematic Review.
    Abe RAM; Masroor A; Khorochkov A; Prieto J; Singh KB; Nnadozie MC; Abdal M; Shrestha N; Mohammed L
    Cureus; 2021 Aug; 13(8):e16855. PubMed ID: 34522493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamins and non-alcoholic fatty liver disease: A Molecular Insight
    Raza S; Tewari A; Rajak S; Sinha RA
    Liver Res; 2021 Jun; 5(2):62-71. PubMed ID: 34221537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between vitamin D and non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: results from a meta-analysis.
    Wang X; Li W; Zhang Y; Yang Y; Qin G
    Int J Clin Exp Med; 2015; 8(10):17221-34. PubMed ID: 26770315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of vitamin D supplement in children with nonalcoholic fatty liver disease: A protocol for systematic review and meta-analysis.
    Liu J; Wang T; Chen J; Zhang Y; Yin X; Fan X; Chen Q
    Medicine (Baltimore); 2020 Jul; 99(31):e20960. PubMed ID: 32756082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decoding the Pathophysiology of Non-alcoholic Fatty Liver Disease Progressing to Non-alcoholic Steatohepatitis: A Systematic Review.
    Yaqub S; Ananias P; Shah A; Luenam K; Jose AM; Melo JP; Turkistani A; Mohammed L
    Cureus; 2021 Sep; 13(9):e18201. PubMed ID: 34722019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of nutraceuticals for the treatment of non-alcoholic fatty liver disease.
    Del Ben M; Polimeni L; Baratta F; Pastori D; Angelico F
    Br J Clin Pharmacol; 2017 Jan; 83(1):88-95. PubMed ID: 26852185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D and Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): An Update.
    Barchetta I; Cimini FA; Cavallo MG
    Nutrients; 2020 Oct; 12(11):. PubMed ID: 33126575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonalcoholic Fatty liver disease/non-alcoholic steatohepatitis in childhood: endocrine-metabolic "mal-programming".
    Manti S; Romano C; Chirico V; Filippelli M; Cuppari C; Loddo I; Salpietro C; Arrigo T
    Hepat Mon; 2014 May; 14(5):e17641. PubMed ID: 24829591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of vitamin E in non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomised controlled trials.
    Amanullah I; Khan YH; Anwar I; Gulzar A; Mallhi TH; Raja AA
    Postgrad Med J; 2019 Nov; 95(1129):601-611. PubMed ID: 31434683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and prevention.
    Tacke F; Weiskirchen R
    Ann Transl Med; 2021 Apr; 9(8):729. PubMed ID: 33987427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of vitamin E in nonalcoholic fatty liver disease.
    Nagashimada M; Ota T
    IUBMB Life; 2019 Apr; 71(4):516-522. PubMed ID: 30592129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible Hepatoprotective Effect of Tocotrienol-Rich Fraction Vitamin E in Non-alcoholic Fatty Liver Disease in Obese Children and Adolescents.
    Al-Baiaty FDR; Ismail A; Abdul Latiff Z; Muhammad Nawawi KN; Raja Ali RA; Mokhtar NM
    Front Pediatr; 2021; 9():667247. PubMed ID: 34307250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A narrative review on effects of vitamin D on main risk factors and severity of Non-Alcoholic Fatty Liver Disease.
    Sangouni AA; Ghavamzadeh S; Jamalzehi A
    Diabetes Metab Syndr; 2019; 13(3):2260-2265. PubMed ID: 31235166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin E and Pioglitazone: A Comprehensive Systematic Review of Their Efficacy in Non-alcoholic Fatty Liver Disease.
    Mazhar IJ; Yasir M; Sarfraz S; Shlaghya G; Narayana SH; Mushtaq U; Shaman Ameen B; Nie C; Nechi D; Penumetcha SS
    Cureus; 2023 Aug; 15(8):e43635. PubMed ID: 37719477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-alcoholic fatty liver disease.
    Smith BW; Adams LA
    Crit Rev Clin Lab Sci; 2011; 48(3):97-113. PubMed ID: 21875310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-Alcoholic Fatty Liver Disease Treatment in Patients with Type 2 Diabetes Mellitus; New Kids on the Block.
    Athyros VG; Polyzos SA; Kountouras J; Katsiki N; Anagnostis P; Doumas M; Mantzoros CS
    Curr Vasc Pharmacol; 2020; 18(2):172-181. PubMed ID: 30961499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD).
    Saeed A; Dullaart RPF; Schreuder TCMA; Blokzijl H; Faber KN
    Nutrients; 2017 Dec; 10(1):. PubMed ID: 29286303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between Vitamin D Levels and Nonalcoholic Fatty Liver Disease: Potential Confounding Variables.
    Pacifico L; Osborn JF; Bonci E; Pierimarchi P; Chiesa C
    Mini Rev Med Chem; 2019; 19(4):310-332. PubMed ID: 30360708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review with meta-analysis: non-alcoholic steatohepatitis - a case for personalised treatment based on pathogenic targets.
    Younossi ZM; Reyes MJ; Mishra A; Mehta R; Henry L
    Aliment Pharmacol Ther; 2014 Jan; 39(1):3-14. PubMed ID: 24206433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetics in non-alcoholic fatty liver disease.
    Lee J; Kim Y; Friso S; Choi SW
    Mol Aspects Med; 2017 Apr; 54():78-88. PubMed ID: 27889327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.